Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Rubén Mesa"'
Autor:
Teófilo Lozano, Carolina Wiesner, Rubén Mesa, Marie Emanuel Robyn, Martha Suárez, Edgar Salguero
Publikováno v:
Revista Ciencias de la Salud, Vol 15, Iss 3 (2017)
Objetivo: validar na Colômbia, a escala abreviada de sintomas representativos de neoplasias mieloproliferativas, para u seu posterior uso em investigação e a sua aplicação no âmbito clínico. Materiais e métodos: realizouse a adaptaç
Externí odkaz:
https://doaj.org/article/e3d4d3d3e7f0431e9eb4c4ad8b5555fd
Autor:
Stephen T. Oh, Srdan Verstovsek, Vikas Gupta, Uwe Platzbecker, Timothy Devos, Jean‐Jacques Kiladjian, Donal P. McLornan, Andrew Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J. Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Publikováno v:
eJHaem, Vol 5, Iss 1, Pp 105-116 (2024)
Abstract Bone marrow fibrosis (BMF) is a pathological feature of myelofibrosis, with higher grades associated with poor prognosis. Limited data exist on the association between outcomes and BMF changes. We present BMF data from Janus kinase (JAK) inh
Externí odkaz:
https://doaj.org/article/e5b1d836647843f987f4afa02212f957
Autor:
Lai Yee Orbell, Nouf Abutheraa, Andrew S Duncombe, Mary Frances McMullin, Ruben Mesa, Charlene M McShane, Glen James, Lesley A Anderson
Publikováno v:
eJHaem, Vol 4, Iss 4, Pp 1071-1080 (2023)
Abstract Alleviating symptom burden in patients with myeloproliferative neoplasms (MPNs) is imperative to achieving optimal management. Research remains to elucidate the relationship between the JAK2V617F (Janus kinase 2) mutation present in many MPN
Externí odkaz:
https://doaj.org/article/028c2022644a45cea8818fdbea71bab2
Autor:
Srdan Verstovsek, Ruben Mesa, Moshe Talpaz, Jean-Jacques Kiladjian, Claire N. Harrison, Stephen T. Oh, Alessandro M. Vannucchi, Raajit Rampal, Bart L. Scott, Sarah A. Buckley, Adam R. Craig, Karisse Roman-Torres, John O. Mascarenhas
Publikováno v:
Haematologica, Vol 109, Iss 4 (2024)
Externí odkaz:
https://doaj.org/article/203a9fa1d46d4f9081e247e6b964ffb0
Autor:
Pankit Vachhani, John Mascarenhas, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M. Palmer, Aaron T. Gerds, Lucia Masarova, Andrew T. Kuykendall, Raajit K. Rampal, Ruben Mesa, Srdan Verstovsek
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Interferons are cytokines with immunomodulatory properties and disease-modifying effects that have been used to treat myeloproliferative neoplasms (MPNs) for more than 35 years. The initial use of interferons was limited due to difficulties with admi
Externí odkaz:
https://doaj.org/article/f914014456cf435ebd924c6e619ff22a
Autor:
Srdan Verstovsek, Moshe Talpaz, Martha Wadleigh, Alessandro Isidori, Peter te Boekhorst, Michael R. Savona, Prithviraj Bose, Olga Pozdnyakova, Ruben Mesa, Tarec C. El-Galaly, Jennifer O’Sullivan, Katia Gamel, Brian Higgins, Sudhakar Katakam, Boyan Todorov, Kerstin Trunzer, Claire N. Harrison
Publikováno v:
Haematologica, Vol 109, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/76abace3898a49739eb80acbf94a2b4d
Autor:
Shenghui Wu, Yanning Liu, Melanie Williams, Christine Aguilar, Amelie G Ramirez, Ruben Mesa, Gail E Tomlinson
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303725 (2024)
[This corrects the article DOI: 10.1371/journal.pone.0278354.].
Externí odkaz:
https://doaj.org/article/0c609a6e55ea46bd9ddbb3dbc4d0ef3e
Autor:
Jean-Jacques Kiladjian, Alessandro M. Vannucchi, Aaron T. Gerds, Vikas Gupta, Srdan Verstovsek, Miklos Egyed, Uwe Platzbecker, Jiří Mayer, Sebastian Grosicki, Árpád Illés, Tomasz Woźny, Stephen T. Oh, Donal McLornan, Ilya Kirgner, Sung-Soo Yoon, Claire N. Harrison, Barbara Klencke, Mei Huang, Jun Kawashima, Ruben Mesa
Publikováno v:
HemaSphere, Vol 7, Iss 11, p e963 (2023)
The oral activin A receptor type I, Janus kinase 1 (JAK1), and JAK2 inhibitor momelotinib demonstrated symptom, spleen, and anemia benefits in intermediate- and high-risk myelofibrosis (MF). Post hoc analyses herein evaluated the efficacy and safety
Externí odkaz:
https://doaj.org/article/8aa5ca705d5c48c7b3d8bea3c0ceae9d
Autor:
Naveen Pemmaraju, Claire Harrison, Vikas Gupta, Srdan Verstovsek, Bart Scott, Stephen T. Oh, Francesca Palandri, Haifa Kathrin Al‐Ali, Marta Sobas, Mary Frances McMullin, Ruben Mesa, Sarah Buckley, Karisse Roman‐Torres, Alessandro Vannucchi, Abdulraheem Yacoub
Publikováno v:
eJHaem, Vol 3, Iss 4, Pp 1346-1351 (2022)
Abstract The safety profile of the novel oral JAK2/IRAK1 inhibitor pacritinib in patients with cytopenic myelofibrosis was described in the Phase 2 PAC203 and Phase 3 PERSIST‐2 studies. To account for longer treatment durations on the pacritinib ar
Externí odkaz:
https://doaj.org/article/574b802e842344f980cc853bce367c39
Autor:
Aaron T. Gerds, Claire Harrison, Jean-Jacques Kiladjian, Ruben Mesa, Alessandro Vannucchi, Rami S. Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam Mead, Jason Gotlib, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne Palmer, Kelly Mccaul, Vincent Ribrag, Srdan Verstovsek, Francesco Passamonti
Publikováno v:
HemaSphere, Vol 7, p e0882611 (2023)
Externí odkaz:
https://doaj.org/article/c45032cc341b4a4c9484e09d00786e90